FallberichtOpen Access
Drug-Induced Immune Hemolytic Anemia Following Dapagliflozin Administration: A Case Report
Cureus · 25.02.2025
DOI: 10.7759/cureus.79630 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 25.02.2025. Verfasst von Bergen Lemack und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Texas College of Osteopathic Medicine, Fort Worth, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
adverse drug reactiondapagliflozindrug-induced immune hemolytic anemiahemolytic anemiajaundice
Autor:innen und Institutionen
- College of Medicine, Texas College of Osteopathic Medicine, Fort Worth, USA.
- Internal Medicine, Texas Health Huguley Hospital, Burleson, USA.
Zitieren
APA
Lemack, B., Kupovics, G., & Kumar, R. (2025). Drug-Induced Immune Hemolytic Anemia Following Dapagliflozin Administration: A Case Report. Cureus. https://doi.org/10.7759/cureus.79630
Vancouver
Lemack B, Kupovics G, Kumar R. Drug-Induced Immune Hemolytic Anemia Following Dapagliflozin Administration: A Case Report. Cureus. 2025. doi:10.7759/cureus.79630
BibTeX
@article{Lemack2025,
author = {Lemack, Bergen and Kupovics, Gabriel and Kumar, Rohit},
title = {Drug-Induced Immune Hemolytic Anemia Following Dapagliflozin Administration: A Case Report},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.79630}
}
EUVIMED